Nektar Therapeutics
NKTR
#4926
Rank
A$2.87 B
Marketcap
A$84.14
Share price
-2.56%
Change (1 day)
-6.00%
Change (1 year)

Earnings for Nektar Therapeutics (NKTR)

Earnings in 2026 (TTM): -A$0.23 Billion

According to Nektar Therapeutics 's latest financial reports the company's current earnings are A$54.58 Million. In 2025 the company made an earning of -A$0.23 Billion a decrease over its 2024 earnings that were of -A$0.18 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Nektar Therapeutics from 1994 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) -A$0.23 Billion1.37%
2025 -A$0.23 Billion30.44%
2024 -A$0.18 Billion-56.85%
2023 -A$0.4 Billion-24.31%
2022 -A$0.53 Billion-30.25%
2021 -A$0.75 Billion17.87%
2020 -A$0.64 Billion0.88%
2019 -A$0.63 Billion-164.46%
2018 A$0.97 B-810.61%
2017 -A$0.14 Billion-37.06%
2016 -A$0.22 Billion89.22%
2015 -A$0.12 Billion48.22%
2014 -A$77.82 Million-65.93%
2013 -A$0.23 Billion-6.81%
2012 -A$0.25 Billion28.95%
2011 -A$0.2 Billion258.8%
2010 -A$52.99 Million-63.94%
2009 -A$0.15 Billion-392.45%
2008 A$50.24 M-211.74%
2007 -A$44.97 Million-79.57%
2006 -A$0.23 Billion-16.9%
2005 -A$0.27 Billion81.53%
2004 -A$0.15 Billion54.19%
2003 -A$94.63 Million-33.87%
2002 -A$0.15 Billion-9.6%
2001 -A$0.16 Billion73.39%
2000 -A$91.29 Million108.9%
1999 -A$43.7 Million39.48%
1998 -A$31.33 Million60.02%
1997 -A$19.58 Million18.05%
1996 -A$16.59 Million31.82%
1995 -A$12.59 Million57.14%
1994 -A$8.01 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Johnson & Johnson
JNJ
A$37.46 B-17,216.66%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
A$9.87 B-4,611.02%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
A$14.70 B-6,818.52%๐Ÿ‡บ๐Ÿ‡ธ USA
Baxter
BAX
-A$0.7 Billion 215.45%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
A$10.99 B-5,122.40%๐Ÿ‡บ๐Ÿ‡ธ USA
AstraZeneca
AZN
A$20.49 B-9,460.35%๐Ÿ‡ฌ๐Ÿ‡ง UK
Richardson Electronics
RELL
A$10.69 M-104.88%๐Ÿ‡บ๐Ÿ‡ธ USA
Alkermes
ALKS
A$0.33 B-254.92%๐Ÿ‡ฎ๐Ÿ‡ช Ireland